Trial Profile
Escitalopram for the Treatment of Postpartum Depression.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Postnatal depression
- Focus Therapeutic Use
- Acronyms LexaproPPD
- 28 Mar 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jul 2011 Planned end date changed from Jan 2009 to Nov 2011 as reported by ClinicalTrials.gov.
- 06 Feb 2009 New trial record